T1	Participants 520 602	Eighty-nine suppressed patients > or =18 years old with CD4 counts >50 cells/mm(3)
T2	Participants 103 122	suppressed patients
T3	Participants 753 772	Eighty-one patients
T4	Participants 1576 1694	Patients who experience virologic suppression with a regimen of lamivudine 150 mg BID in combination with stavudine/PI
